Hence, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rodent model of PD, dopaminergic neurons were protected by the treatment with non-selective NOS inhibitors or gene deletion of the iNOS gene [38]. Here, NOS2 is linked to Parkinson disease.